Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5ad8562c578b061df7a2c3aee9d0e24 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 |
filingDate |
2014-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_194a293f0fd247e2f348c5fa0896ec67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e15bc86bf20110b6fcd6a044e3997a8b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_192d3358500549eab653a1d1b0e2e1f7 |
publicationDate |
2016-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20160004648-A |
titleOfInvention |
Cyclic phosphopeptide compounds as allosteric plk1-pbd inhibitor |
abstract |
The present invention relates to a novel cyclic phosphopeptide compound having an allosteric PLK1-PBD inhibitory activity, and the compound of the present invention is useful as an antitumor agent since it has PLK1-PBD inhibitory activity. |
priorityDate |
2014-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |